MedTrace Logo

NT-proBNP in ICU Postoperative/Posttraumatic Patients With Shock

NCT00736723 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 51

Last updated 2025-01-01

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine the course of NT-proBNP plasma concentrations in the context of confounding parameters in postoperative/posttraumatic critically ill patients with severe SIRS/sepsis and shock.

Conditions

  • SIRS
  • Sepsis
  • Shock
  • Critically Ill
  • Multiple Organ Dysfunction Syndrome

Sponsors & Collaborators

  • University of Ulm

    lead OTHER

Principal Investigators

  • Manfred Weiss, MD, MBA · Clinic of Anesthesiology, University Hospital Medical School, Steinhoevelstrasse 9, 89070 Ulm, Germany

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2012-08-31
Completion
2012-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00736723 on ClinicalTrials.gov